Generalized Hypertrichosis Due to Secukinumab in a Patient with Moderate Psoriasis: A Case of Serendipity or Zemblanity?
April 2019
in “
Dermatologic therapy
”
Studysummary This case report described a 67-year-old man with moderate psoriasis who developed persistent generalized hypertrichosis after 4 months of treatment with secukinumab.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
After 4 months of treatment with secukinumab for moderate psoriasis, a 67-year-old male patient experienced generalized hypertrichosis, which is an unusual increase in hair growth, while also achieving a 90% improvement in the Psoriasis Area and Severity Index (PASI 90). The patient reported no other drug use or application of creams that could account for this side effect. Despite the unexpected hair growth, the patient was not troubled by it and chose to continue the therapy, resulting in the persistence of both the hypertrichosis and the control of his psoriasis symptoms.
